Ajanta Pharma launches Memantine Hydrochloride Tablets in US market

14 Jun 2016 Evaluate

Ajanta Pharma has launched Memantine Hydrochloride Tablets in the US market through its wholly owned subsidiary Ajanta Pharma USA Inc. Memantine Hydrochloride is an anti-dementia drug and is a bioequivalent generic version of Namenda. The company has launched it in 2 strengths 5mg & 10mg tablets to address different levels of treatment.

Memantine Hydrochloride Tablets is part of an ever-growing portfolio of products that Ajanta has developed for the US market. Till date, the United States Food & Drug Administration (USFDA) has granted 10 final approvals and 2 tentative approvals to Ajanta Pharma for its Abbreviated New Drug Application (ANDA). Additional 14 ANDAs are pending approval from the USFDA.

Ajanta Pharma is a specialty pharmaceutical formulation company with global headquarters in Mumbai, India. Over 6,000 employees are engaged in developing, manufacturing and marketing of quality finished dosages across 30+ countries.

Ajanta Pharma Share Price

2638.75 12.50 (0.48%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×